学术探索
学术期刊
新闻热点
数据分析
智能评审

Interleukin 2 in the management of acute leukaemia

被引：20
作者：
Foa, R [1 ]
机构：
[1] UNIV TURIN, CNR, CTR IMMUNOGENET & ONCOL SPERIMENTALE, TURIN, ITALY
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 92卷 / 01期
关键词：
IL2; acute leukaemia; immunotherapy; gene therapy;
D O I：
10.1046/j.1365-2141.1996.270834.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 8
页数：8
相关论文
共 85 条
[61]  
MILLER AR, 1993, BLOOD, V82, P3686
[62]   T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE-LEUKEMIA USING CAMPATH-1 ANTIBODIES AND POSTTRANSPLANT ADMINISTRATION OF DONORS PERIPHERAL-BLOOD LYMPHOCYTES FOR PREVENTION OF RELAPSE [J].
NAPARSTEK, E ;
OR, R ;
NAGLER, A ;
CIVIDALLI, G ;
ENGELHARD, D ;
AKER, M ;
GIMON, Z ;
MANNY, N ;
SACKS, T ;
TOCHNER, Z ;
WEISS, L ;
SAMUEL, S ;
BRAUTBAR, C ;
HALE, G ;
WALDMANN, H ;
STEINBERG, SM ;
SLAVIN, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) :506-515
[63]  
NEUBAUER MA, 1994, BONE MARROW TRANSPL, V13, P311
[64]  
OSHIMI K, 1986, BLOOD, V68, P938
[65]   THROMBOCYTOPENIA DURING IMMUNOTHERAPY WITH INTERLEUKIN-2 BY CONSTANT INFUSION [J].
PACIUCCI, PA ;
MANDELI, J ;
OLEKSOWICZ, L ;
AMEGLIO, F ;
HOLLAND, JF .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) :308-312
[66]   INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
PAPADOPOULOS, EB ;
LADANYI, M ;
EMANUEL, D ;
MACKINNON, S ;
BOULAD, F ;
CARABASI, MH ;
CASTROMALASPINA, H ;
CHILDS, BH ;
GILLIO, AP ;
SMALL, TN ;
YOUNG, JW ;
KERNAN, NA ;
OREILLY, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1185-1191
[67]  
PIZZOLO G, 1993, LEUKEMIA, V7, P418
[68]  
REITTIE JE, 1989, BLOOD, V73, P1351
[69]   USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION [J].
ROONEY, CM ;
SMITH, CA ;
NG, CYC ;
LOFTIN, S ;
LI, CF ;
KRANCE, RA ;
BRENNER, MK ;
HESLOP, HE .
LANCET, 1995, 345 (8941) :9-13
[70]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897
123456789